( 02157.hk) | 27.74 | 5.23 | 0% | 上市时间2022-02-23股价4.47港币涨跌幅-7.45%成交金额6,227.46万港币换手率0.77%市值80.66亿港币H股市值80.66亿港币总股本18.04亿H股本18.04亿每手股数1,000上市至今年化投资收益率-10.01%港股通持仓占H股比例31.23% (27.56亿港币2026-07-15) 累计做空占H股比例0.94% (7,415.33万港币2026-07-10) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 116.80 | 市净率 | 4.26 | 股息率 | 0.39% | 恒生:医疗保健业药品及生物科技生物技术 |
| 所属指数指数纳入纳出 | |||||||
| 备注 (3): | 双击编辑备注 |
乐普生物(02157) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 華風茂 | Independent Non Executive Director - A/F | 2021-12-16 | -- | |
| 2 | 楊海峰 | Independent Non Executive Director | 2020-12-10 | -- | |
| 3 | 周德敏 | Independent Non Executive Director | 2020-12-10 | -- | |
| 4 | 胡朝紅 | Executive Director | CEO | 2020-05-16 | -- |
| 5 | 林向紅 | Non Executive Director | 2020-04-22 | -- | |
| 6 | 蒲珏 | Non Executive Director | 2020-04-22 | -- | |
| 7 | 隋滋野 | Executive Director | CEO | 2020-04-22 | -- |
| 8 | 楊紅冰 | Non Executive Director | 2020-04-22 | -- | |
| 9 | 蒲忠傑 | Executive Director | Chairman | 2018-01-19 | -- |